- Home
- RFI vs LFCR Comparison
RFI vs LFCR Comparison
Compare RFI & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RFI | LFCR |
|---|---|---|
| Founded | 1992 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 294.2M | 296.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | RFI | LFCR |
|---|---|---|
| Price | $11.05 | $7.69 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 69.8K | ★ 160.9K |
| Earning Date | 01-01-0001 | 01-02-2026 |
| Dividend Yield | ★ 8.25% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $128,867,000.00 |
| Revenue This Year | N/A | $2.80 |
| Revenue Next Year | N/A | $11.51 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 0.47 |
| 52 Week Low | $9.62 | $4.76 |
| 52 Week High | $12.52 | $8.85 |
Technical Indicators
Market Signals| Indicator | RFI | LFCR |
|---|---|---|
| Relative Strength Index (RSI) | 29.95 | 52.61 |
| Support Level | $11.06 | $7.50 |
| Resistance Level | $11.46 | $7.87 |
| Average True Range (ATR) | 0.13 | 0.28 |
| MACD | -0.01 | -0.04 |
| Stochastic Oscillator | 0.00 | 51.47 |
Price Performance
Historical ComparisonAbout RFI Cohen & Steers Total Return Realty Fund Inc.
Cohen & Steers Total Return Realty Fund Inc is a diversified, closed-end management investment company. Its investment objective is to achieve a high total return through investment in real estate securities. The Fund invests majority of its total assets in the equity securities of real estate companies under normal circumstances, which includes common shares, REITs, rights or warrants, convertible securities, and preferred shares.
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.